BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9301453)

  • 1. Interaction of spontaneous and organised screening for cervical cancer in Turin, Italy.
    Ronco G; Segnan N; Giordano L; Pilutti S; Senore C; Ponti A; Volante R
    Eur J Cancer; 1997 Jul; 33(8):1262-7. PubMed ID: 9301453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992-98.
    Ronco G; Pilutti S; Patriarca S; Montanari G; Ghiringhello B; Volante R; Giordano L; Zanetti R; Mancini E; Segnan N;
    Br J Cancer; 2005 Aug; 93(3):376-8. PubMed ID: 16012518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity level and process indicators of organised programmes for cervical cancer screening in Italy.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2006; 30(1 Suppl 3):27-40. PubMed ID: 16937844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening in Italy.
    Segnan N; Ronco G; Ciatto S
    Eur J Cancer; 2000 Nov; 36(17):2235-9. PubMed ID: 11072211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
    Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
    Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organised cervical cancer screening still leads to higher coverage than spontaneous screening in The Netherlands.
    Bos AB; van Ballegooijen M; van Gessel-Dabekaussen AA; Habbema JD
    Eur J Cancer; 1998 Sep; 34(10):1598-601. PubMed ID: 9893635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of Pap-test coverage in an area with an organised screening program: challenges for survey methods.
    Giorgi Rossi P; Esposito G; Brezzi S; Brachini A; Raggi P; Federici A
    BMC Health Serv Res; 2006 Mar; 6():36. PubMed ID: 16545125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening programme in Finland.
    Anttila A; Nieminen P
    Eur J Cancer; 2000 Nov; 36(17):2209-14. PubMed ID: 11072206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
    Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
    BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer screening monitoring system: indicators for organised programmes and possible extension to spontaneous screening.
    Giorgi Rossi P; Federici A; Zappa M
    Pathologica; 2013 Jun; 105(3):83-5. PubMed ID: 24047033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening in Greece.
    Riza E; Kyriakogianni-Psaropoulou P; Koumantakis E; Symiakaki H; Garas I; Linos A
    Eur J Cancer; 2000 Nov; 36(17):2227-32. PubMed ID: 11072209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based organized cervical cancer screening pilot program in France.
    Hamers FF; Duport N; Beltzer N
    Eur J Cancer Prev; 2018 Sep; 27(5):486-492. PubMed ID: 28362653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assurance in cervical cancer screening: the Icelandic experience 1964-1993.
    Sigurdsson K
    Eur J Cancer; 1995; 31A(5):728-34. PubMed ID: 7640046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening in Belgium.
    Arbyn M; Van Oyen H
    Eur J Cancer; 2000 Nov; 36(17):2191-7. PubMed ID: 11072203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effective policies for cervical cancer screening. An international review.
    Fahs MC; Plichta SB; Mandelblatt JS
    Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.